Columbia researchers have discovered how a genetic defect leads to spinal muscular atrophy, a finding that could lead to a new therapy for a disease that affects 1 in 6,000 children.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
A study of long-acting injectable antipsychotics for people with schizophrenia found that newer medication was no more effective than older, less expensive medication.
Racial disparities in stroke are due primarily to higher rates and poorer treatment of hypertension, diabetes, and high cholesterol among black Americans.
Researchers have identified two types of neurons that enable the spinal cord to control skilled forelimb movement. The findings could lead to new ways to treat movement disorders.